Koninklijke Philips Operating Expenses 2010-2025 | PHG

Koninklijke Philips annual/quarterly operating expenses history and growth rate from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Koninklijke Philips operating expenses for the quarter ending June 30, 2025 were $4.469B, a 3.51% decline year-over-year.
  • Koninklijke Philips operating expenses for the twelve months ending June 30, 2025 were $16.990B, a 11.32% decline year-over-year.
  • Koninklijke Philips annual operating expenses for 2024 were $18.928B, a 4.35% decline from 2023.
  • Koninklijke Philips annual operating expenses for 2023 were $19.789B, a 2.96% decline from 2022.
  • Koninklijke Philips annual operating expenses for 2022 were $20.392B, a 3.82% increase from 2021.
Koninklijke Philips Annual Operating Expenses
(Millions of US $)
2024 $18,928
2023 $19,789
2022 $20,392
2021 $19,643
2020 $20,553
2019 $19,977
2018 $19,372
2017 $18,382
2016 $25,047
2015 $25,819
2014 $27,789
2013 $28,343
2012 $30,555
2011 $30,005
2010 $31,115
2009 $31,565
Koninklijke Philips Quarterly Operating Expenses
(Millions of US $)
2025-06-30 $4,469
2025-03-31 $4,153
2024-09-30 $4,441
2024-06-30 $3,926
2023-06-30 $4,632
2023-03-31 $5,099
2022-06-30 $4,433
2021-06-30 $4,994
2020-06-30 $4,587
2019-06-30 $4,858
2018-06-30 $4,758
2017-06-30 $4,446
2016-12-31 $6,940
2016-09-30 $6,043
2016-06-30 $6,197
2016-03-31 $5,867
2015-12-31 $7,615
2015-09-30 $6,113
2015-06-30 $6,222
2015-03-31 $5,869
2014-12-31 $6,932
2014-09-30 $7,481
2014-06-30 $6,806
2014-03-31 $6,570
2013-12-31 $8,254
2013-09-30 $6,828
2013-06-30 $6,719
2013-03-31 $6,542
2012-12-31 $9,545
2012-09-30 $7,251
2012-06-30 $6,982
2012-03-31 $6,778
2011-12-31 $8,838
2011-09-30 $7,248
2011-06-30 $7,167
2011-03-31 $6,752
2010-12-31 $9,074
2010-09-30 $7,313
2010-06-30 $7,385
2010-03-31 $7,343
2009-12-31 $8,462
2009-09-30 $7,701
2009-06-30 $8,511
2009-03-31 $6,892
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $26.557B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.889B 27.07
Boston Scientific (BSX) United States $156.325B 37.28
Stryker (SYK) United States $149.639B 30.46
EssilorLuxottica (ESLOY) France $141.259B 0.00
Medtronic (MDT) Ireland $119.046B 16.78
Lonza Group Ag (LZAGY) Switzerland $49.750B 0.00
Haleon (HLN) United Kingdom $43.937B 25.13
ResMed (RMD) United States $40.192B 28.75
Agilent Technologies (A) United States $35.696B 23.06
GE HealthCare Technologies (GEHC) United States $33.662B 15.82
Terumo (TRUMY) Japan $26.606B 31.53
Insulet (PODD) United States $23.925B 80.16
Zimmer Biomet Holdings (ZBH) United States $21.018B 13.38
Smith & Nephew SNATS (SNN) United Kingdom $16.402B 0.00
Baxter (BAX) United States $12.681B 9.80
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $8.061B 29.61
Lantheus Holdings (LNTH) United States $3.733B 10.09
Envista Holdings (NVST) United States $3.520B 24.63
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Prestige Consumer Healthcare (PBH) United States $3.349B 14.86
Perrigo (PRGO) Ireland $3.266B 8.16
ICU Medical (ICUI) United States $3.151B 21.45
Haemonetics (HAE) United States $2.628B 11.73
Acuren (TIC) United States $2.261B 0.00
Curaleaf Holdings (CURLF) Canada $2.213B 0.00
LeMaitre Vascular (LMAT) United States $2.159B 46.29
QuidelOrtho (QDEL) United States $1.948B 12.26
Green Thumb Industries (GTBIF) United States $1.840B 79.00
AtriCure (ATRC) United States $1.838B 0.00
Tilray Brands (TLRY) Canada $1.519B 0.00
Phibro Animal Health (PAHC) United States $1.503B 17.74
AdaptHealth (AHCO) United States $1.284B 18.25
Neogen (NEOG) United States $1.249B 19.83
BioLife Solutions (BLFS) United States $1.200B 2505.00
InMode (INMD) Israel $0.944B 8.74
Kestra Medical Technologies (KMTS) United States $0.829B 0.00
Valneva SE (VALN) France $0.753B 0.00
Cresco Labs (CRLBF) United States $0.740B 0.00
SNDL (SNDL) Canada $0.704B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.618B 0.00
Verano Holdings (VRNOF) United States $0.615B 0.00
ZimVie (ZIMV) United States $0.532B 20.52
Evolus (EOLS) United States $0.494B 0.00
Surmodics (SRDX) United States $0.487B 0.00
VAREX IMAGING (VREX) United States $0.479B 16.50
CeriBell (CBLL) United States $0.434B 0.00
Canopy Growth (CGC) Canada $0.432B 0.00
Owens & Minor (OMI) United States $0.379B 3.36
Sanuwave Health (SNWV) United States $0.357B 0.00
TerrAscend (TSNDF) Canada $0.352B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Aurora Cannabis (ACB) Canada $0.306B 0.00
Sanara MedTech (SMTI) United States $0.300B 0.00
Brainsway (BWAY) Israel $0.294B 59.85
High Tide (HITI) Canada $0.292B 0.00
Capricor Therapeutics (CAPR) United States $0.287B 0.00
Viemed Healthcare (VMD) United States $0.286B 21.68
Omeros (OMER) United States $0.283B 0.00
TriSalus Life Sciences (TLSI) United States $0.260B 0.00
Cerus (CERS) United States $0.251B 0.00
OraSure Technologies (OSUR) United States $0.242B 0.00
Organigram Global (OGI) Canada $0.232B 0.00
Vireo Growth (VREOF) United States $0.219B 0.00
Exagen (XGN) United States $0.217B 0.00
Quanterix (QTRX) United States $0.211B 0.00
Utah Medical Products (UTMD) United States $0.199B 16.63
FitLife Brands (FTLF) United States $0.175B 0.00
Biote (BTMD) United States $0.170B 5.64
Jushi Holdings (JUSHF) United States $0.149B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
MacroGenics (MGNX) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.111B 0.00
Fonar (FONR) United States $0.099B 12.78
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Apyx Medical (APYX) United States $0.075B 0.00
Agape ATP (ATPC) $0.066B 0.00
Safety Shot (SHOT) United States $0.062B 0.00
MariMed (MRMD) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
Rockwell Medical (RMTI) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.058B 33.68
Zynex (ZYXI) United States $0.050B 0.00
Veru (VERU) United States $0.048B 0.00
Modular Medical (MODD) United States $0.040B 0.00
Nephros (NEPH) United States $0.040B 31.08
United-Guardian (UG) United States $0.039B 15.02
Senestech (SNES) United States $0.024B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
INLIF (INLF) $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Sharps Technology (STSS) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00